These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

757 related items for PubMed ID: 28456525

  • 1. Homologous and heterologous antigenic matched vaccines containing different H5 hemagglutinins provide variable protection of chickens from the 2014 U.S. H5N8 and H5N2 clade 2.3.4.4 highly pathogenic avian influenza viruses.
    Kapczynski DR, Pantin-Jackwood MJ, Spackman E, Chrzastek K, Suarez DL, Swayne DE.
    Vaccine; 2017 Nov 01; 35(46):6345-6353. PubMed ID: 28456525
    [Abstract] [Full Text] [Related]

  • 2. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.
    Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y.
    Vaccine; 2015 Feb 25; 33(9):1197-205. PubMed ID: 25613723
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Protection of White Leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus.
    Bertran K, Balzli C, Lee DH, Suarez DL, Kapczynski DR, Swayne DE.
    Vaccine; 2017 Nov 01; 35(46):6336-6344. PubMed ID: 28554502
    [Abstract] [Full Text] [Related]

  • 5. Protection Afforded by a Recombinant Turkey Herpesvirus-H5 Vaccine Against the 2014 European Highly Pathogenic H5N8 Avian Influenza Strain.
    Steensels M, Rauw F, van den Berg T, Marché S, Gardin Y, Palya V, Lambrecht B.
    Avian Dis; 2016 May 01; 60(1 Suppl):202-9. PubMed ID: 27309056
    [Abstract] [Full Text] [Related]

  • 6. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X, Chen P, Liu L, Deng G, Li Y, Shi J, Kong H, Feng H, Bai J, Li X, Shi W, Tian G, Chen H.
    Avian Dis; 2016 May 01; 60(1 Suppl):253-5. PubMed ID: 27309064
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE, Suarez DL, Spackman E, Jadhao S, Dauphin G, Kim-Torchetti M, McGrane J, Weaver J, Daniels P, Wong F, Selleck P, Wiyono A, Indriani R, Yupiana Y, Sawitri Siregar E, Prajitno T, Smith D, Fouchier R.
    J Virol; 2015 Apr 01; 89(7):3746-62. PubMed ID: 25609805
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
    Bertran K, Kassa A, Criado MF, Nuñez IA, Lee DH, Killmaster L, Sá E Silva M, Ross TM, Mebatsion T, Pritchard N, Swayne DE.
    Vaccine; 2021 Apr 01; 39(14):1933-1942. PubMed ID: 33715903
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Two Licensed Avian Influenza H5 Vaccines Against Challenge with a 2015 U.S. H5N2 clade 2.3.4.4 Highly Pathogenic Avian Influenza Virus in Domestic Ducks.
    Pantin-Jackwood MJ, DeJesus E, Costa-Hurtado M, Smith D, Chrzastek K, Kapczynski DR, Suarez DL.
    Avian Dis; 2019 Mar 01; 63(1):90-96. PubMed ID: 31251524
    [Abstract] [Full Text] [Related]

  • 15. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M, Pritchard N, Swayne DE, Selleck P, Karaca K, Suarez DL, Audonnet JC, Mickle TR.
    Ann N Y Acad Sci; 2006 Oct 01; 1081():193-201. PubMed ID: 17135511
    [Abstract] [Full Text] [Related]

  • 16. A two dose immunization with an inactivated reassortant H5N2 virus protects chickens against lethal challenge with homologous 2.3.2.1 clade and heterologous 2.2 clade highly pathogenic avian influenza H5N1 viruses.
    Bhat S, Sood R, Shukla S, Khandia R, Pateriya AK, Kumar N, Singh VK, Kalaiyarasu S, Kumar M, Bhatia S.
    Vet Microbiol; 2018 Apr 01; 217():149-157. PubMed ID: 29615248
    [Abstract] [Full Text] [Related]

  • 17. Protective efficacy of a prime-boost protocol using H5-DNA plasmid as prime and inactivated H5N2 vaccine as the booster against the Egyptian avian influenza challenge virus.
    Hussein HA, Ahmed BM, Aly SM, El-Deeb AH, El-Sanousi AA, Rohaim MA, Arafa AA, Gadalla MR.
    Acta Virol; 2016 Apr 01; 60(3):307-15. PubMed ID: 27640441
    [Abstract] [Full Text] [Related]

  • 18. Protection of White Leghorn chickens by recombinant fowlpox vector vaccine with an updated H5 insert against Mexican H5N2 avian influenza viruses.
    Bertran K, Criado MF, Lee DH, Killmaster L, Sá E Silva M, Lucio E, Widener J, Pritchard N, Atkins E, Mebatsion T, Swayne DE.
    Vaccine; 2020 Feb 05; 38(6):1526-1534. PubMed ID: 31862196
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of recombinant H5 vaccines delivered in ovo or day of age in commercial broilers against the 2015 U.S. H5N2 clade 2.3.4.4c highly pathogenic avian Influenza virus.
    Kapczynski DR, Chrzastek K, Shanmugasundaram R, Zsak A, Segovia K, Sellers H, Suarez DL.
    Virol J; 2023 Dec 15; 20(1):298. PubMed ID: 38102683
    [Abstract] [Full Text] [Related]

  • 20. Examination of the protective efficacy of two avian influenza H5 vaccines against clade 2.3.4.4b H5N8 highly pathogenic avian influenza virus in commercial broilers.
    El-Shall NA, Awad AM, Sedeik ME.
    Res Vet Sci; 2021 Nov 15; 140():125-133. PubMed ID: 34425414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.